Particle.news

Download on the App Store

Melinda French Gates, Wellcome Leap Launch $100 Million Push to Close Women’s Health Research Gap

The DARPA-style effort is pitched as a catalyst to draw more public and private co-investors into underfunded women’s health R&D.

Overview

  • Pivotal Ventures and Wellcome Leap are committing $50 million each to a new $100 million fund to accelerate women’s health research.
  • The effort will concentrate on conditions that affect women differently or disproportionately, including cardiovascular disease, autoimmune disorders and mental health.
  • Two priority programs will be selected by the end of 2026, with launches planned for 2026 and targeted outcomes in three to five years.
  • Organizers cite a persistent funding gap, noting that only about 1% of pharmaceutical research outside cancer went to women’s health in 2024.
  • With this partnership, Wellcome Leap’s women’s health commitments rise toward $250 million as it pursues $1 billion in philanthropic capital, complementing the Gates Foundation’s recent $2.5 billion pledge through 2030.